Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published January 3, 2012 | Accepted Version
Journal Article Open

Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior

Abstract

Firing rates of dopamine (DA) neurons in substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) control DA release in target structures such as striatum and prefrontal cortex. DA neuron firing in the soma and release probability at axon terminals are tightly regulated by cholinergic transmission and nicotinic acetylcholine receptors (nAChRs). To understand the role of α6* nAChRs in DA transmission, we studied several strains of mice expressing differing levels of mutant, hypersensitive (leucine 9′ to serine [L9′S]) α6 subunits. α6 L9′S mice harboring six or more copies of the hypersensitive α6 gene exhibited spontaneous home-cage hyperactivity and novelty-induced locomotor activity, whereas mice with an equal number of WT and L9′S α6 genes had locomotor activity resembling that of control mice. α6-dependent, nicotine-stimulated locomotor activation was also more robust in high-copy α6 L9′S mice versus low-copy mice. In wheel-running experiments, results were also bi-modal; high-copy α6 L9′S animals exhibited blunted total wheel rotations during each day of a 9-day experiment, but low-copy α6 L9′S mice ran normally on the wheel. Reduced wheel running in hyperactive strains of α6 L9′S mice was attributable to a reduction in both overall running time and velocity. ACh and nicotine-stimulated DA release from striatal synaptosomes in α6 L9′S mice was well-correlated with behavioral phenotypes, supporting the hypothesis that augmented DA release mediates the altered behavior of α6 L9′S mice. This study highlights the precise control that the nicotinic cholinergic system exerts on DA transmission and provides further insights into the mechanisms and consequences of enhanced DA release.

Additional Information

© 2011 IBRO. Published by Elsevier Ltd. Accepted 24 October 2011. Available online 04 November 2011. We thank members of the Lester laboratory for helpful discussion. This work was supported by National Institutes of Health (NIH) grants (DA17279, DA12242, DA015663, DA03194, MH53631, GM48677, and DA030396). R.M.D. was supported by a fellowship from the California Tobacco Related Disease Research Program (15FT-0030), an NIH National Research Service Award (DA021492), and an NIH Pathway to Independence Award (DA030396).

Attached Files

Accepted Version - nihms-336935.pdf

Files

nihms-336935.pdf
Files (973.6 kB)
Name Size Download all
md5:a63fb52251e6996bfd59dea0f67a9612
973.6 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 24, 2023